August 1, 2025 | AI, Patient Retention, clinical trials, patient recruitment
Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by streamlining the drug development process and helping to generate more robust data, which will inevitably aid regulatory decision-making.

Eloise Moffatt, our Vice President of Commercial, joined other industry experts during a webinar about AI trends and technologies for 2025. They discussed the benefits that AI and machine learning (ML) can bring to clinical trials and the potential pitfalls that require careful consideration.
Read more here
This content was provided by Innovative Trials
Company Details
Latest Content from Innovative Trials
Kate Shaw, founder and CEO of Innovative Trials, a global clinical trial patient recruitment and retention company, won the ‘Woman in Pharma’ at the Pharma Industry Awards UK. She was…
Patient recruitment company, Innovative Trials, has been nominated as a finalist in 2 categories at the Pharma Industry Award Read the full press release 👉🏽 https://bit.ly/3MdzBwf
Join the upcoming webinar which will discuss key patient recruitment & retention challenges and solutions for upcoming influenza studies.
This white paper explores the importance of patient-first services and why direct patient support is crucial for the success of sponsors’ clinical trials. Download it for FREE 👉🏽 https://innovativetrials.com/six-reasons-why-direct-patient-support-is-a-must-have-for-your-clinical-trials/
Step into the realm of innovation and collaboration in patient recruitment and retention with our upcoming webinar, “Bridging Boundaries: Uniting Communities for Rare Disease Clinical Trial Success.” Delve deep into…
In the landscape of the clinical trial industry in 2024, persistent challenges persist in the realms of patient recruitment and retention. These hurdles, having endured over several years, continue to…
Clinical trial patient recruitment and retention remains one of the key challenges to successfully bringing a new therapeutic to market. An estimated 85% of clinical trials face delays due to…
Innovative Trials, a global patient recruitment and retention company, has just announced GOSH Charity and Oliver Patch Project as their charity partners of the year
Join this live webinar focusing on patient recruitment and retention in rare disease trials.
A partnership between Innovative Trials and the non-profit Oliver Patch Project to boost retention in pediatric studies
